Cargando…

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023

BACKGROUND: This retrospective observational matched-cohort study of 2,151,216 individuals from the Korean coronavirus disease 2019 (COVID-19) vaccine effectiveness cohort aimed to evaluate the comparative effectiveness of the COVID-19 bivalent versus monovalent vaccines in providing additional prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ryu Kyung, Choe, Young June, Jang, Eun Jung, Chae, Chungman, Hwang, Ji Hae, Lee, Kil Hun, Shim, Ji Ae, Kwon, Geun-Yong, Lee, Jae Young, Park, Young-Joon, Lee, Sang Won, Kwon, Donghyok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681846/ https://www.ncbi.nlm.nih.gov/pubmed/38013649 http://dx.doi.org/10.3346/jkms.2023.38.e396

Ejemplares similares

Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease
por: Liu, D., et al.
Publicado: (2019)

Preliminary Study on the Host Response to Bivalent and Monovalent Autogenous Vaccines against Mycoplasma agalactiae in Dairy Sheep
por: Hussein, Hany A., et al.
Publicado: (2022)

Effect of monovalent and bivalent live attenuated vaccines against QX-like IBV infection in young chickens
por: Yang, Chen-Yu, et al.
Publicado: (2023)

Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea
por: KIM, Ah-Young, et al.
Publicado: (2017)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
por: Hultqvist, Greta, et al.
Publicado: (2017)

Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines
por: Ye, Zi-Wei, et al.
Publicado: (2022)

Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
por: Resch, Matthew D., et al.
Publicado: (2022)

Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
por: Li, Wanting, et al.
Publicado: (2023)

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
por: Wang, Qian, et al.
Publicado: (2023)

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
por: Branche, Angela R., et al.
Publicado: (2023)

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
por: Park, Sang-Hyun, et al.
Publicado: (2021)

Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- and Long-Distance Conformational Changes
por: Corazza, Alessandra, et al.
Publicado: (2019)

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
por: Saxena, Divyasha, et al.
Publicado: (2023)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines
por: Choi, Kang-Seuk
Publicado: (2017)

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
por: Edeling, Melissa A., et al.
Publicado: (2014)

An orienting response is not enough: Bivalency not infrequency causes the bivalency effect
por: Rey-Mermet, Alodie, et al.
Publicado: (2013)

A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
por: Yang, Siyeon, et al.
Publicado: (2020)

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
por: Harper, Diane M., et al.
Publicado: (2011)

Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides
por: Zeigler, David F., et al.
Publicado: (2017)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Axillary lymphadenopathy following bivalent COVID-19 booster vaccination
por: Lane, Elizabeth G., et al.
Publicado: (2023)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report
por: Chen, Ssu-Yu, et al.
Publicado: (2023)

A Hitchhiker's Guide to Worldwide COVID-19 Vaccinations: A Detailed Review of Monovalent and Bivalent Vaccine Schedules, COVID-19 Vaccine Side Effects, and Effectiveness Against Omicron and Delta Variants
por: Goyal, Lokesh, et al.
Publicado: (2022)

Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
por: Zheng, Xiaoyan, et al.
Publicado: (2017)

Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103
por: Park, Deok Bum, et al.
Publicado: (2021)

An essential role for UTX in resolution and activation of bivalent promoters
por: Dhar, Shilpa S., et al.
Publicado: (2016)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
por: Shi, Li-Wei, et al.
Publicado: (2023)

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia
por: Holmes, Marionette, et al.
Publicado: (2017)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Engineering a Novel Bivalent Oral Vaccine against Enteric Fever
por: Soulier, Annelise, et al.
Publicado: (2021)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Hammad, Noha M., et al.
Publicado: (2021)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
por: Chalkias, Spyros, et al.
Publicado: (2022)

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
por: Hoffmann, Markus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q1q4ahqqtm3v47p1sj8svdf39b